시장보고서
상품코드
1756464

세계의 저체온 치료 시스템 시장 : 제품 종류별, 용도별, 최종 용도별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Therapeutic Hypothermia Systems Market, By Product Type, By Application, By End Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 399 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

저체온 치료 시스템의 시장 규모는 2024년 3억 380만 달러로 2024년부터 2032년까지 CAGR 6.50%로 성장할 것으로 예상됩니다.

저체온 치료 시스템 시장 역학

심정지 및 신경질환 발생률 증가

심정지 및 신경 질환의 유병률 증가는 저체온 치료 시스템에 대한 수요를 촉진하는 주요 촉진요인입니다. 전 세계적으로 병원 밖 심정지(OHCA)는 매년 수십만 명에게 영향을 미치며, 효과적인 소생술 후 치료 없이는 생존율이 낮습니다. 치료적 저체온 요법은 이러한 사례에서 신경학적 회복을 개선하고 사망률을 낮추기 위한 표준적인 개입으로 등장했습니다. 또한, 외상성 뇌손상(TBI), 뇌졸중, 신생아 뇌병증의 증가와 관리된 냉각이 임상적으로 유익한 것으로 밝혀짐에 따라 이러한 시스템의 도입이 더욱 가속화되고 있습니다. 응급 대응 인프라의 발전과 더불어 표적 체온 관리를 위한 치료적 저체온 요법을 권장하는 업데이트된 임상 가이드라인이 중환자 치료 프로토콜에의 통합을 촉진하고 있습니다. 또한, 심혈관계 및 신경계 질환에 취약한 세계 인구의 고령화는 장기적인 수요를 유지할 것으로 보입니다. 이러한 요인들이 종합적으로 의료 환경에서 효율적이고 사용하기 쉬운 치료용 저체온 치료 기술에 대한 수요가 증가하고 있음을 강조하고 있습니다.

저체온 치료 시스템 시장 : 주요 인사이트

당사의 리서치 애널리스트에 따르면, 세계 저체온 치료 시스템 시장은 2024년부터 2032년까지 약 6.50%의 CAGR로 성장할 것으로 예상됩니다.

제품 유형별로는 2023년 냉각장치가 시장을 독점하고 있습니다.

용도별로는 2023년 심장병이 가장 높은 수익을 창출했습니다.

지역별로는 2023년 북미가 가장 높은 수익을 올린 지역으로 나타났습니다.

저체온 치료 시스템 시장 : 세분화 분석

세계 저체온 치료 시스템 시장은 제품 유형, 용도, 최종 용도, 지역 등 세 가지로 분류됩니다.

저체온 치료 시스템 시장은 제품 유형에 따라 냉각 장치, 냉각 카테터, 냉각 팩, 기타 제품 유형으로 구분됩니다. 이 중 냉각 장치는 고도의 온도 제어, 사용 편의성, 다양한 의료 응급 상황에서 광범위한 임상 적용 가능성으로 인해 시장을 지배할 것으로 예상됩니다. 이러한 장치에는 냉각 담요, 패드, 자동 체온 조절 장치와 같은 표면 냉각 시스템이 포함되어 정확하고 신속한 체온 관리를 제공합니다. 비침습적 특성과 일관되게 제어된 저체온 요법을 제공할 수 있는 능력으로 인해 중환자실, 응급실, 수술실에서 매우 선호되고 있습니다. 휴대용 자동화 시스템 등 냉각 장치 설계의 기술적 발전은 그 채택을 더욱 촉진하고 있습니다. 또한, 심정지 및 신경 손상에 대한 조기 체온 중재의 이점에 대한 인식이 높아짐에 따라 의료 서비스 제공자는 고성능 냉각 장치에 대한 투자를 늘리고 있습니다. 또한, 성인과 소아 환자 모두에 적용할 수 있어 적용 범위가 넓어지고 있습니다. 또한, 미국심장협회(AHA)와 같은 기관의 유리한 상환 정책 및 지지적인 임상 가이드라인으로 인해 주요 제품 유형으로서의 입지가 강화되고 있습니다. 이러한 장점들은 전체적으로 저체온 치료 시스템 시장에서 냉각 장치가 지속적으로 우위를 점하는 데 기여하고 있습니다.

저체온 치료 시스템 시장은 용도별로 신경증, 심장질환, 신생아 의료, 기타 용도로 구분됩니다. 그 중에서도 순환기과는 심정지 발생률의 증가와 소생 후 표적 체온관리(TTM)의 채택 확대가 주요 요인으로 작용하여 시장을 독점할 것으로 예상됩니다. 치료용 저체온 요법은 갑작스런 심정지 환자의 생존율과 신경학적 예후를 개선하는 것으로 임상적으로 입증되었습니다. 전 세계적으로 심혈관계 질환의 유병률은 지속적으로 증가하고 있으며, 특히 고령화 사회로 인해 순환기 내과에서 저체온 치료 시스템에 대한 수요는 꾸준히 증가할 것으로 예상됩니다. 또한, 주요 의료기관의 확립된 임상 가이드라인에서 심정지 후 제어된 저체온 요법의 사용을 강력히 권장하고 있어 심장 치료 현장에서 저체온 요법의 보급을 더욱 촉진하고 있습니다. 임상적 유효성, 인지도의 향상, 기술 발전의 조합으로 심장 질환이 이 시장의 주요 응용 분야로 남을 것이 확실시됩니다.

저체온 치료 시스템 시장 : 지역별 분석

지역적으로 저체온 치료 시스템 시장은 북미, 아시아태평양, 라틴아메리카, 유럽, 중동 및 아프리카에 분포되어 있습니다. 이 지역은 비즈니스를 가져오는 국가에 따라 더 세분화됩니다.

북미가 시장을 주도할 것으로 예측되는 주요 이유는 첨단 의료 인프라의 존재, 심정지 후 치료에 대한 높은 인식, 미국 및 캐나다와 같은 국가에서 유리한 상환 정책 등입니다. 특히 미국에서는 강력한 임상 가이드라인과 정부의 재정 지원으로 병원과 응급실에서 저체온 치료 시스템이 널리 사용되고 있습니다.

유럽은 확립된 의료 프로토콜, 고령화 인구 증가, 집중 치료 기술에 대한 강력한 투자로 인해 두 번째 주요 지역이 되었습니다. 독일, 영국, 프랑스 등의 국가들이 주요 도입국이며, 공공 및 민간 의료 지원의 혜택을 받고 있습니다. 북미와 유럽은 빠른 기술 도입과 탄탄한 임상적 프레임워크로 인해 시장 점유율의 대부분을 차지하고 있습니다.

저체온 치료 시스템 시장 : 경쟁 상황

저체온 치료 시스템 시장의 경쟁 구도는 세계 의료기기 대기업과 신흥 혁신가들에 의해 형성되고 있습니다. ZOLL Medical Corporation, Becton, Dickinson and Company, Stryker Corporation 등 주요 기업들은 종합적인 포트폴리오와 세계 진출로 이 시장을 독점하고 있습니다. 종합적인 포트폴리오와 전 세계적인 확장으로 이 시장을 독점하고 있습니다. 이들 기업은 정밀 냉각 기술의 발전, 안전성 향상, 규제 준수를 위해 연구개발에 많은 투자를 하고 있습니다. 반면 Belmont Medical Technologies, Life Recovery Systems, PFM Medical HICO GmbH와 같은 중견 기업들은 휴대용 냉각 솔루션이나 신생아 냉각 솔루션과 같은 특정 용도에 집중하고 있습니다. MiraCradle(Plus Advanced Technologies Pvt. Ltd.) 및 VNG Medical Innovation System Pvt. Ltd.와 같은 신생 기업들은 개발도상국을 대상으로 한 비용 효율적이고 혁신적인 장비에 중점을 두고 있습니다. 2023년 6월 벡톤 디킨슨의 전략적 매각과 같은 최근의 움직임은 현재 진행 중인 포트폴리오 재구성을 시사합니다. 경쟁은 기술 혁신을 촉진하고, 중환자 치료 현장에서의 채택을 촉진하며, 지속적인 제품 강화와 지역 확장을 통해 환자 결과를 개선할 수 있습니다.

목차

제1장 저체온 치료 시스템 시장 개요

  • 분석 범위
  • 시장 추정 기간

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 저체온 치료 시스템의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 저체온 치료 시스템 시장 : 산업 분석

  • PEST 분석
  • Porter's Five Forces 분석
  • 시장 성장 전망 : 매핑
  • 규제 체제 분석

제5장 저체온 치료 시스템 시장 : 신종 코로나바이러스 감염증(COVID-19)의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 저체온 치료 시스템 시장 상황

  • 저체온 치료 시스템 시장 점유율 분석(2023년)
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 저체온 치료 시스템 시장 : 제품 종류별

  • 개요
    • 부문별 점유율 분석 : 제품 종류별
    • 냉각 장치
    • 냉각 카테터
    • 냉각 팩
    • 기타 제품 종류

제8장 저체온 치료 시스템 시장 : 용도별

  • 개요
    • 부문별 점유율 분석 : 용도별
    • 신경증
    • 심장병
    • 신생아 의료
    • 기타 용도

제9장 저체온 치료 시스템 시장 : 최종 용도별

  • 개요
    • 부문별 점유율 분석 : 최종 용도별
    • 병원
    • 전문 클리닉
    • 외래 수술 센터

제10장 저체온 치료 시스템 시장 : 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 영국
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 한국
    • 일본
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 튀르키예
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 : 저체온 치료 시스템 업계

  • 경쟁 대시보드
  • 기업 개요
    • Asahi Kasei Corporation(Zoll Medical Corporation)
    • Becton, Dickinson And Company
    • Stryker Corporation
    • Belmont Medical Technologies
    • International Biomedical Ltd.
    • Em-Med
    • Phoenix Medical Systems
    • Life Recovery Systems
    • Shenzhen Comen Medical Instruments Co., Ltd.
    • Miracradle(Pluss Advanced Technologies Pvt. Ltd.)
    • Terumo Cardiovascular Systems Corporation
    • Pfm Medical Hico Gmbh
    • Vng Medical Innovation System Pvt. Ltd
    • Aspen Systems
    • Cooltech Medical
    • Others

제12장 AnalystView의 전방위적 분석

ksm 25.07.03

REPORT HIGHLIGHT

Therapeutic Hypothermia Systems Market size was valued at USD 303.8 Million in 2024, expanding at a CAGR of 6.50% from 2024 to 2032.

Therapeutic hypothermia systems are medical devices designed to lower a patient's body temperature in a controlled manner to reduce the risk of tissue damage following events such as cardiac arrest, traumatic brain injury, or stroke. These systems work by cooling the body to a target temperature usually between 32°C and 36°C to slow metabolic processes, decrease oxygen demand, and limit the cascade of cellular damage. The cooling can be achieved through surface methods, such as cooling blankets or pads, or internal methods using catheters that circulate cooled fluids. Advanced systems allow for precise temperature control, rewarming, and continuous monitoring. Therapeutic hypothermia has been shown to improve neurological outcomes and survival rates when applied shortly after a critical medical event. These systems are used primarily in intensive care units, emergency settings, and surgical procedures. The effectiveness of therapeutic hypothermia depends on timely initiation, duration of cooling, and patient-specific considerations.

Therapeutic Hypothermia Systems Market- Market Dynamics

Rising Incidence of Cardiac Arrest and Neurological Disorders

The growing prevalence of cardiac arrest and neurological conditions is a key driver propelling the demand for therapeutic hypothermia systems. Globally, out-of-hospital cardiac arrests (OHCA) affect hundreds of thousands of individuals annually, with survival rates remaining low without effective post-resuscitation care. Therapeutic hypothermia has emerged as a standard intervention to improve neurological recovery and reduce mortality in such cases. Additionally, increasing cases of traumatic brain injury (TBI), stroke, and neonatal encephalopathy conditions where controlled cooling has shown clinical benefits are further accelerating the adoption of these systems. Advancements in emergency response infrastructure, along with updated clinical guidelines recommending therapeutic hypothermia for targeted temperature management, are supporting its integration into critical care protocols. Moreover, the aging global population, which is more susceptible to cardiovascular and neurological events, is likely to sustain long-term demand. These factors collectively underscore the growing need for efficient, user-friendly therapeutic hypothermia technologies in healthcare settings.

THERAPEUTIC HYPOTHERMIA SYSTEMS Market- Key Insights

According to our research analyst, the global Therapeutic Hypothermia Systems Market is expected to develop at a CAGR of approximately 6.50% between 2024-2032.

Segmented by Product Type in 2023, the Cooling Devices category dominated the market.

Based on Application segmentation, Cardiology generated the most income in 2023.

Based on region, in 2023, North America was the region with the highest revenue.

Therapeutic Hypothermia Systems Market- Segmentation Analysis:

The global Therapeutic Hypothermia Systems market is divided into three categories: product type, application, end use and region.

The therapeutic hypothermia systems market is segmented by product type into Cooling Devices, Cooling Catheters, Cooling Packs, and Other Product Types. Among these, Cooling Devices are projected to dominate the market due to their advanced temperature control, ease of use, and broad clinical applicability across various medical emergencies. These devices include surface cooling systems such as cooling blankets, pads, and automated temperature regulation units that offer precise and rapid body temperature management. Their non-invasive nature, combined with the ability to provide consistent and controlled hypothermia therapy, makes them highly preferred in intensive care units, emergency departments, and surgical settings. Technological advancements in cooling device design, including portable and automated systems, have further enhanced their adoption. Moreover, as awareness grows around the benefits of early temperature intervention in cardiac arrest and neurological injuries, healthcare providers are increasingly investing in high-performance cooling devices. Their capability to cater to both adult and pediatric patients also broadens their application scope. Additionally, favorable reimbursement policies and supportive clinical guidelines from institutions like the American Heart Association (AHA) reinforce their position as the leading product type. These advantages collectively contribute to the expected continued dominance of cooling devices in the therapeutic hypothermia systems market.

The therapeutic hypothermia systems market is segmented by application into Neurology, Cardiology, Neonatal Care, and Other Applications. Among these, Cardiology is expected to dominate the market, driven primarily by the rising incidence of cardiac arrest and the growing adoption of targeted temperature management (TTM) post-resuscitation. Therapeutic hypothermia has been clinically validated to improve survival rates and neurological outcomes in patients who suffer from sudden cardiac arrest, especially when implemented within a critical time window. As global cardiovascular disease rates continue to climb, particularly among aging populations, the demand for hypothermia systems in cardiology is anticipated to increase steadily. Furthermore, established clinical guidelines from major health organizations strongly recommend the use of controlled hypothermia following cardiac arrest, further reinforcing its widespread application in cardiac care settings. The combination of clinical efficacy, growing awareness, and technological advancements ensures cardiology remains the leading application segment within this market.

Therapeutic Hypothermia Systems Market- Geographical Insights

Geographically, the Therapeutic Hypothermia Systems Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is projected to lead the market, primarily due to the presence of advanced healthcare infrastructure, high awareness of post-cardiac arrest care, and favorable reimbursement policies in countries such as the United States and Canada. The U.S., in particular, has widespread adoption of therapeutic hypothermia systems across hospitals and emergency care units, supported by strong clinical guidelines and government funding.

Europe follows as the second dominant region, driven by established medical protocols, a rising aging population, and strong investments in intensive care technologies. Countries such as Germany, the United Kingdom, and France are leading adopters, benefitting from both public and private healthcare support. Together, North America and Europe account for the majority share due to early technology adoption and robust clinical frameworks.

Therapeutic Hypothermia Systems Market- Competitive Landscape:

The competitive landscape of the Therapeutic Hypothermia Systems market is shaped by a mix of global medical device giants and emerging innovators. Leading players such as ASAHI KASEI CORPORATION (ZOLL Medical Corporation), Becton, Dickinson and Company, and Stryker Corporation dominate the space through comprehensive portfolios and global reach. These companies invest substantially in R&D to advance precision cooling technologies, enhance safety, and ensure regulatory compliance. Meanwhile, mid-sized firms like Belmont Medical Technologies, Life Recovery Systems, and PFM Medical HICO GmbH focus on specific applications, including portable and neonatal cooling solutions. Emerging players such as MiraCradle (Pluss Advanced Technologies Pvt. Ltd.) and VNG Medical Innovation System Pvt. Ltd. emphasize cost-effective and innovative devices targeting developing regions. Recent moves, like Becton Dickinson's strategic divestments in June 2023, signal ongoing portfolio realignment. The competition fosters innovation, boosts adoption across critical care settings, and improves patient outcomes through continuous product enhancement and geographic expansion.

Recent Developments:

In January 2024, SourceMark Medical expanded its partnership with Gentherm Medical, becoming the master supplier of Gentherm's patient temperature management products, including the Gelli-Roll reusable warming and cooling gel pad, in the U.S. market.

In July 2023, ZOLL Medical entered into an exclusive distribution agreement with BrainCool AB for the BrainCool System/IQool System and IQool System Pads in the U.S. and key European markets, with plans to expand into select Asian markets.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Asahi Kasei Corporation (Zoll Medical Corporation)
  • Becton, Dickinson And Company
  • Stryker Corporation
  • Belmont Medical Technologies
  • International Biomedical Ltd.
  • Em-Med
  • Phoenix Medical Systems
  • Life Recovery Systems
  • Shenzhen Comen Medical Instruments Co., Ltd.
  • Miracradle (Pluss Advanced Technologies Pvt. Ltd.)
  • Terumo Cardiovascular Systems Corporation
  • Pfm Medical Hico Gmbh
  • Vng Medical Innovation System Pvt. Ltd
  • Aspen Systems
  • Cooltech Medical
  • Others

GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cooling Devices
  • Cooling Catheters
  • Cooling Packs
  • Other Product Types

GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Neurology
  • Cardiology
  • Neonatal Care
  • Other Applications

GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Therapeutic Hypothermia Systems Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Therapeutic Hypothermia Systems Market Snippet by Product Type
    • 2.1.2. Therapeutic Hypothermia Systems Market Snippet by Application
    • 2.1.3. Therapeutic Hypothermia Systems Market Snippet by End Use
    • 2.1.4. Therapeutic Hypothermia Systems Market Snippet by Country
    • 2.1.5. Therapeutic Hypothermia Systems Market Snippet by Region
  • 2.2. Competitive Insights

3. Therapeutic Hypothermia Systems Key Market Trends

  • 3.1. Therapeutic Hypothermia Systems Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Therapeutic Hypothermia Systems Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Therapeutic Hypothermia Systems Market Opportunities
  • 3.4. Therapeutic Hypothermia Systems Market Future Trends

4. Therapeutic Hypothermia Systems Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Therapeutic Hypothermia Systems Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Therapeutic Hypothermia Systems Market Landscape

  • 6.1. Therapeutic Hypothermia Systems Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Therapeutic Hypothermia Systems Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Cooling Devices
    • 7.1.3. Cooling Catheters
    • 7.1.4. Cooling Packs
    • 7.1.5. Other Product Types

8. Therapeutic Hypothermia Systems Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Neurology
    • 8.1.3. Cardiology
    • 8.1.4. Neonatal Care
    • 8.1.5. Other Applications

9. Therapeutic Hypothermia Systems Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2023 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Specialty Clinics
    • 9.1.4. Ambulatory Surgival Centers

10. Therapeutic Hypothermia Systems Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Therapeutic Hypothermia Systems Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Therapeutic Hypothermia Systems Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Therapeutic Hypothermia Systems Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Therapeutic Hypothermia Systems Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Therapeutic Hypothermia Systems Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Therapeutic Hypothermia Systems Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Asahi Kasei Corporation (Zoll Medical Corporation)
    • 11.2.2. Becton, Dickinson And Company
    • 11.2.3. Stryker Corporation
    • 11.2.4. Belmont Medical Technologies
    • 11.2.5. International Biomedical Ltd.
    • 11.2.6. Em-Med
    • 11.2.7. Phoenix Medical Systems
    • 11.2.8. Life Recovery Systems
    • 11.2.9. Shenzhen Comen Medical Instruments Co., Ltd.
    • 11.2.10. Miracradle (Pluss Advanced Technologies Pvt. Ltd.)
    • 11.2.11. Terumo Cardiovascular Systems Corporation
    • 11.2.12. Pfm Medical Hico Gmbh
    • 11.2.13. Vng Medical Innovation System Pvt. Ltd
    • 11.2.14. Aspen Systems
    • 11.2.15. Cooltech Medical
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제